MRC2 and neoplasm: These data, in agreement with our current and other studies28, suggest that loss of Endo180 in normal tissues can be compensated for, but that under conditions where matrix remodelling is compromised such as by loss of MT1-MMP or in the altered conditions of the tumour microenvironment, a requirement for functional Endo180 is revealed.